{"PubmedArticle": [{"MedlineCitation": {"KeywordList": [["Boswellia", "Complementary Therapies", "Diabetes Mellitus", "Herbal Medicine", "Lipids"]], "OtherID": [], "CitationSubset": [], "InvestigatorList": [], "SpaceFlightMission": [], "GeneralNote": [], "OtherAbstract": [], "PMID": "27840532", "DateRevised": {"Year": "2020", "Month": "09", "Day": "30"}, "Article": {"ArticleDate": [], "ELocationID": [], "Language": ["eng"], "Journal": {"ISSN": "0253-0716", "JournalIssue": {"Volume": "41", "Issue": "3 Suppl", "PubDate": {"Year": "2016", "Month": "May"}}, "Title": "Iranian journal of medical sciences", "ISOAbbreviation": "Iran J Med Sci"}, "ArticleTitle": "The Efficacy of Boswellia Serrata Gum Resin for Control of Lipid Profile and Blood Glucose in Diabetic Patients.", "Pagination": {"StartPage": "S66", "MedlinePgn": "S66"}, "Abstract": {"AbstractText": ["Regarding preclinical evidence for antidiabetic effects of Boswellia serrata, we evaluated anti-hyperglycemic and lipid-lowering effects of Boswellia serrate gum resin in type 2 diabetic patients in a double-blind randomized placebo-control trial.", "Fifty-six diabetic patients were randomly allocated to two groups to receive 250 mg of the Boswellia serrate gum resin or placebo twice daily for 8 weeks, in addition to their routine antidiabetic treatments. Fasting blood sugar (FBS), glycosylated hemoglobin (HbA1c), insulin level, total cholesterol, low-density lipoprotein (LDL), high-density lipoprotein (HDL) and triglyceride of serum were measured before and after the intervention.", "Although there was a considerable reduction after the intervention in FBS (P=0.04), HbA1c (P=0.02) and triglyceride (P=0.01) in the Boswellia serrate gum resin group, no significant difference was observed in all outcome measures between the two groups at the end of the study (FBS P=0.09, HbA1c P=0.20, total cholesterol P=0.31, LDL P=0.49, HDL P=0.10, triglyceride P=0.78 and insulin level P=0.86).", "The current study showed the 8 weeks complementary use of Boswellia serrate gum resin with a daily dose of 500 mg had no better glucose and lipid lowering effect than placebo in diabetic patients."]}, "AuthorList": [{"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Pharmacology, School of Medicine, Iran University of Medical Sciences, Tehran, Iran."}], "LastName": "Mehrzadi", "ForeName": "Saeed", "Initials": "S"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Pharmacology, Alborz University of Medical Sciences, Karaj, Alborz, Iran."}], "LastName": "Tavakolifar", "ForeName": "Bahreh", "Initials": "B"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Medicinal Plants Research Center, Institute of Medicinal Plants, ACECR, Karaj, Iran."}], "LastName": "Huseini", "ForeName": "Hasan Fallah", "Initials": "HF"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Research Center for Traditional Medicine and History of Medicine, Shiraz University of Medical Sciences, Shiraz, Iran."}], "LastName": "Mosavat", "ForeName": "Seyed Hamdollah", "Initials": "SH"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Research Center for Traditional Medicine and History of Medicine, Shiraz University of Medical Sciences, Shiraz, Iran."}], "LastName": "Heydari", "ForeName": "Mojtaba", "Initials": "M"}], "PublicationTypeList": ["Journal Article"]}, "MedlineJournalInfo": {"Country": "Iran", "MedlineTA": "Iran J Med Sci", "NlmUniqueID": "8104374", "ISSNLinking": "0253-0716"}}, "PubmedData": {"ReferenceList": [], "History": [{"Year": "2016", "Month": "11", "Day": "15", "Hour": "6", "Minute": "0"}, {"Year": "2016", "Month": "11", "Day": "15", "Hour": "6", "Minute": "0"}, {"Year": "2016", "Month": "11", "Day": "15", "Hour": "6", "Minute": "1"}, {"Year": "2016", "Month": "5", "Day": "1"}], "PublicationStatus": "ppublish", "ArticleIdList": ["27840532", "PMC5103576"]}}], "PubmedBookArticle": []}